Filing Details
- Accession Number:
- 0001593968-19-001642
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-18 17:12:47
- Reporting Period:
- 2019-07-18
- Accepted Time:
- 2019-07-18 17:12:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1671584 | Aptevo Therapeutics Inc. | APVO | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1380185 | Fuad El-Hibri | 2401 4Th Avenue Suite 1050 Seattle WA 98121 | Board Of Directors | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-07-18 | 14,404 | $0.87 | 903,061 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The purchase price of $0.8745 is reflective of the weighted average purchase price. The prices for the transactions reported on this line range from $0.86 to $0.89. Mr. El-Hibri undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.